Recently Viewed

News Announcement

Marksans Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

15-Oct-2025 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

Marksans Pharma Limiteds wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for it products from UK MHRA.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month